Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 1
1(16.7%)
6Total
N/A(5)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07056374Recruiting

Adaptive Anastomosis for Anterior Resection in Sigmoid and Proximal Rectal Cancer or Premalignant Lesions

Role: collaborator

NCT06615583Not ApplicableNot Yet Recruiting

A Novel Adaptive Anastomotic Technique for Left-sided Colonic Resection

Role: collaborator

NCT06481605Not ApplicableNot Yet Recruiting

A Novel Adaptive Anastomotic Technique for Left-sided Colonic and Rectal Resection

Role: collaborator

NCT04836676Not ApplicableUnknown

Clinical Validation of C-REX Device for Adaptive Anastomoses

Role: lead

NCT03404934Not ApplicableTerminated

Clinical Study Verifying C-REX LapAid in Clinical Practice

Role: lead

NCT03179358Not ApplicableCompleted

Clinical Trial Verifying C-REX LapAid and C-REX DMH/DMHC

Role: lead

NCT01451008Phase 1Completed

Compression Anastomosis Using the Compression Anastomotic Ring-locking Procedure (CARP)

Role: collaborator

All 7 trials loaded